Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus. [electronic resource]
Producer: 20170915Description: 359-369 p. digitalISSN:- 1473-4877
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.